Potential New Pharmacological Approaches in Obese Women with Polycystic Ovary Syndrome

Journal Title: Journal of Diabetes and Obesity - Year 2016, Vol 4, Issue 1

Abstract

Obesity is frequently present in women with polycystic ovary syndrome PCOS It aggravates the adverse features of the syndrome and increases the metabolic risk in this population Weight management by life style intervention often remains unsatisfactory and non-sustainable In the present mini review we revised limited studies addressing the potential use of agents mediating through glucagon-like peptide GLP - 1 in PCOS We reported that short-term intervention with long acting GLP-1 analogue liraglutide is associated with consistent BMI decrease in treatment naive obese women with PCOS and in those who had been previously poor responders to metformin and life style modification Metformin a well-established therapy used in PCOS with high metabolic risk was recognized as a mechanistically well-suited combination with liraglutide Short-term intervention with liraglutide also improved eating behavior in obese PCOS Furthermore we discussed the potential association of genetic variability of GLP-1 receptor and inter-individual differences in response to liraglutide regarding weight reduction In addition we challenged the original concept related to the enhancement of GLP-1 mediated action through phosphordiesterase 4 PDE 4 inhibitions as a new potential therapeutic target in obesity-related population We concluded that GLP-1 mediated agents are promising treatment strategies in the management of obese PCOS However larger sample size studies with longer durations of treatment may be required to examine potential benefits of these medications in decreasing metabolic risk and improving reproductive out come in obese PCOS

Authors and Affiliations

Andrej Janez

Keywords

Related Articles

Insulin Resistance, Impaired fasting, Glucose Intolerance and Type II Diabetes Mellitus in Overweight and Obese Children in Abu Dhabi

Background: Obesity is increasingly seen in children and youth. It is linked to major health concerns including glucose intolerance and type II diabetes. This study aims to assess the prevalence of impaired glucose toler...

Occurrence of Left Ventricular Hypertrophy in Subjects with Metabolic Syndrome: Role of Adiponectin

This study was designed to evaluate the role of total plasma adiponectin ADPN on the occurrence of left ventricular hypertrophy in subjects with metabolic syndrome MetS compared to a control group without MetS The m...

Physiological and Psychological Changes Following Liposuction of Large Volumes of Fat in Overweight and Obese Women

Background: Liposuction can remove a substantial amount of body fat. We investigated the effects of liposuction of large volumes of fat on anthropometrics, body composition (BIA), metabolic hormones, and psychological me...

Risk of Type 2 Diabetes among US - Foreign Born Non-Hispanic Asians: Evidence from NHANES 2011-12

Aims/Introduction: The purpose of this study was to compare risks for metabolic dysfunction and type 2diabetes among Non-Hispanic Asian and Non-Hispanic white adults using new nationally representative data in the U.S. W...

Rapid Perioperative Changes in the Quantitative Properties of Plasma Lipases and Lipoproteins in Morbidly Obese Surgical Patients

Background: The impact of bariatric surgery on abnormalities in blood lipids and lipoprotein metabolism during the perioperative period has been poorly studied. Objective: We studied the impact of bariatric surgery on th...

Download PDF file
  • EP ID EP417852
  • DOI 10.15436/2376-0494.17.1246
  • Views 91
  • Downloads 0

How To Cite

Andrej Janez (2016). Potential New Pharmacological Approaches in Obese Women with Polycystic Ovary Syndrome. Journal of Diabetes and Obesity, 4(1), 0-0. https://europub.co.uk/articles/-A-417852